|
We are very pleased to announce our recent grant recipients. Despite the impact of the COVID-19 pandemic, we were more determined than ever to ensure that CURE Epilepsy continues to advance epilepsy research. The eight novel research projects highlighted here, a combination of Taking Flight and CURE Epilepsy grants, will accelerate our ability to find cures for epilepsy.
|
|
|
These investigators represent a range of young researchers: early in their career, who are “taking flight,” demonstrating their leadership and readiness to establish themselves independent of their mentors, as well as established researchers who are working zealously to further our understanding so we can achieve our goal – a cure for this devastating condition.
Read on to learn more about these novel research projects in acquired epilepsy, genetics, SUDEP, sleep and epilepsy, and more.
|
|
Taking Flight Award Grantees - $100,000 for one year
This award seeks to promote the careers of young epilepsy investigators, allowing them to develop a research focus independent of their mentors.
|
|
Ediberto Amorim de Cerqueira, M.D.
University of California, San Francisco
Dr. Amorim will define EEG signatures that predict seizure risk after an acute brain injury.
Read more »
|
|
|
Mark Bennett, Ph.D.
The Walter and Eliza Hall Institute of Medical Research, Australia
Dr. Bennett will address the role of ‘repeat expansions’ in epilepsy.
Read more »
|
|
|
Ankit Khambhati, Ph.D.
University of California, San Francisco
Dr. Khambhati aims to optimize paradigms used to stimulate the brain with a goal of interfering with seizure activity, leading to faster and more effective control of focal-onset seizures.
Read more »
|
|
|
Cristina Reschke, Ph.D.
Royal College of Surgeons in Ireland
Dr. Reschke will focus on how disruptions of circadian rhythms affect gene expression during development of epilepsy.
Read more »
|
|
|
Ranmal Samarasinghe, M.D., Ph.D.
University of California, Los Angeles
Dr. Samarasinghe will study 3D brain-like structures derived from the cells of people with epilepsy who have a mutation in the SCN8A gene to uncover cellular changes that account for differences in neuronal activity in different areas of the brain.
Read more »
|
|
|
CURE Epilepsy Award Grantees - $250,000 for two years
This award reflects CURE Epilepsy's continued focus on scientific advances that have potential to truly transform the lives of those affected by epilepsy.
|
|
Cristina Gross, Ph.D. and Steven Crone, Ph.D.
Cincinnati Children’s Hospital
Drs. Gross (left) and Crone (below) will use mouse models to test if changes in a specific genetic pathway, called the PI3K/mTOR pathway, lead to breathing abnormalities and Sudden Unexpected Death in Epilepsy (SUDEP).
Read more »
|
|
|
Steven Crone, Ph.D. and Cristina Gross, Ph.D.
Cincinnati Children’s Hospital
Drs. Crone (left) and Gross (above) will use mouse models to test if changes in a specific genetic pathway, called the PI3K/mTOR pathway, lead to breathing abnormalities and Sudden Unexpected Death in Epilepsy (SUDEP).
Read more »
|
|
|
Nuria Lacuey Lecumberri, M.D, Ph.D.
The University of Texas Health Science Center at Houston
Dr. Lecumberri’s project aims to improve the overall understanding of breathing control and how it is associated with SUDEP.
Read more »
|
|
|
Nigel Pedersen, M.D.
Emory University
The goal of Dr. Pedersen’s research is to understand the mechanisms underlying the well-recognized relationship between sleep and epilepsy.
Read more »
|
|
|
|
Our mission is to find a cure for epilepsy, by promoting and funding patient-focused research. CURE Epilepsy is a non-profit 501(c)(3) tax-exempt organization. Our tax identification number is 36-4253176.
|
|
|
|
|
